Huidong Chen

ORCID: 0000-0001-7676-6350
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Mycobacterium research and diagnosis
  • COVID-19 and Mental Health
  • Drug-Induced Hepatotoxicity and Protection
  • Systemic Lupus Erythematosus Research
  • Tuberculosis Research and Epidemiology
  • Healthcare and Venom Research
  • Lymphoma Diagnosis and Treatment
  • Drug Transport and Resistance Mechanisms
  • Pneumonia and Respiratory Infections
  • Gut microbiota and health
  • COVID-19 and healthcare impacts
  • Animal Virus Infections Studies
  • Traditional Chinese Medicine Studies
  • Clostridium difficile and Clostridium perfringens research
  • Infection Control and Ventilation
  • COVID-19 epidemiological studies
  • Rheumatoid Arthritis Research and Therapies

Affiliated Hospital of Southwest Medical University
2025

Jinyintan Hospital
2020-2022

Huazhong University of Science and Technology
2022

Wuhan City Chinese Medicine Hospital
2020

Abstract Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats 1–4 . Previous studies shown that some bat SARSr-CoVs potential to infect humans 5–7 Here we report identification and characterization new coronavirus (2019-nCoV), which caused an epidemic Wuhan, China. The epidemic, started on 12 December 2019, had 2,794 laboratory-confirmed infections...

10.1038/s41586-020-2012-7 article EN cc-by Nature 2020-02-03

SettingThe shorter treatment regimen (STR) for multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) has achieved successful outcomes in many countries. However, there are few studies on high-dose gatifloxacin-based STR with adverse drug reactions (ADRs) and management.DesignA prospective observational study was conducted MDR/RR-TB patients who were treated a standardized 9 12 - month regimen: including gatifloxacin (Gfx), clofazimine (Cfz), ethambutol (EMB), pyrazinamide (PZA),...

10.1016/j.ijid.2021.11.037 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-11-30

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel with higher transmissibility compared SARS (SARS-CoV) and Middle East distress coronavirus. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 an unprecedented global crisis that has not been experienced, which still disrupting health systems, economies, societies around the world rapid spread. Bronchoscopy plays important role in diagnosis therapy of pulmonary diseases, especially patients severe infection,...

10.4103/eus.eus_45_20 article EN Endoscopic Ultrasound 2020-01-01
Coming Soon ...